Learn More
Medchemexpress LLC N-[(6,7-difluoro-1h-benzimidazol-2-yl)methyl]-9-(3-fluorophenyl)-2-(4-morpholinyl)-9h-purin-6-amine | 1454585-06-8 | MFCD30187527 | 99.7% | 480.45 g·mol⁻¹ | C23H19F3N8O | 25 MG

Supplier: Medchemexpress LLC HY10001125MG
SR-3029 is a potent, ATP-competitive inhibitor of casein kinase 1 delta (CK1δ) and epsilon (CK1ε) with characterized biochemical, cellular, and in vivo activity. It is used in kinase signaling and oncology research to probe CK1-dependent pathways and evaluate antiproliferative effects in cell and animal models.
- Potent ATP-competitive inhibitor of CK1δ and CK1ε (IC50s 44 nM and 260 nM).
- Ki of 97 nM against CK1 isoforms.
- Cellular antiproliferative activity with EC50s in the low nanomolar range.
- Demonstrated antitumor activity in multiple xenograft models.
- High reported purity (99.73%).
- Available as solid and solution formats for biochemical and cell-based assays.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.